Determination of hypericin in human plasma by high-performance liquid chromatography after intravesical administration in patients with transitional cell carcinoma of the bladder

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 59, Issue 3, 2005, Pages 469-474

  Kamuhabwa, Appolinary A R ^a   Di Mavungu, José Diana ^b   Baert, Luc ^a   D'Hallewin, Marie Ange ^a   Hoogmartens, Jos ^b   De Witte, Peter A M ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Bladder carcinoma; HPLC; Hypericin; Photodynamic therapy; Plasma

Indexed keywords

AMMONIUM ACETATE; BUFFER; HYPERICIN; METHANOL; PHOTOSENSITIZING AGENT;

ARTICLE; BLADDER CARCINOMA; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DETERMINATION; DRUG INSTILLATION; DRUG ISOLATION; FLUORESCENCE ANALYSIS; HELA CELL; HUMAN; HUMAN CELL; INCUBATION TIME; MALE; PERIPHERAL VEIN; PH MEASUREMENT; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION; TRANSITIONAL CELL CARCINOMA;

EID: 14844294797     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2004.09.013     Document Type: Article

References (25)

1. A.F. Kantor, P. Hartge, R.N. Hoover, and J.F. Fraumeni Epidemiological characteristics of squamous cell carcinoma and adenocarcinoma of the bladder Cancer Res. 48 1988 3853 3855
2. G.R. Prout Bladder carcinoma and a TMN system for classification J. Urol. 117 1997 583 590
3. J. Daly Carcinoma in situ of the urothelium Urol. Clin. North Am. 3 1976 87 92
4. J.F. Kelly, and M.E. Snell Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder J. Urol. 115 1976 150 151
5. M.J. Manyak Photodynamic therapy: principles and urological applications Semin. Urol. 9 1991 192 202
6. L. Baert, R. Berg, M. D'Hallewin, B. Van Damme, K. Svanberg, and S. Svanberg Clinical fluorescence diagnosis of human bladder carcinoma following low Photofrin injection Urology 41 1993 322 330
7. S-C. Chang, A.J. MacRobert, and S.G. Bown Photodynamic therapy on rat urinary bladder with intravesical instillation of 5-aminolevulinic acid: light diffusion and histological changes J. Urol. 155 1996 1749 1753
8. J. Vicente, G. Chèchile, and F. Algaba Value of in vivo mucosa-staining test with methylene blue in the diagnosis of pretumoral and tumoral lesions of the bladder Eur. Urol. 13 1997 15 16
9. M. Kriegmair, R. Baumgartner, R. Kunchel, H. Stepp, F. Hofstadter, and A. Hofstetter Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence J. Urol. 155 1996 105 109
10. M.A. D'Hallewin, H. Vanherzeele, and L. Baert Fluorescence detection of flat transition cell carcinoma after intravesical instillation of aminolevulinic acid Am. J. Clin. Oncol. 21 1998 223 225
11. C.R. Riedl, E. Plas, and H. Pfluger Fluorescence detection of bladder tumors with 5-aminolevulinic acid J. Endourol. 13 1999 755 759
12. N. Lange, P. Jichlinski, M. Zellweger, M. Forrer, A. Marti, L. Guillou, P. Kucera, G. Wagnieres, and H. van den Bergh Photodetection of early human bladder cancer based on the fluorescence of 5-aminolevulinic acid hexylester-induced protoporphyrin IX: a pilot study Br. J. Cancer 80 1999 185 193
13. M.A. D'Hallewin, P.A. de Witte, E. Waelkens, W. Merlevede, and L. Baert Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin J. Urol. 164 2000 349 351
14. M.A. D'Hallewin, A.R. Kamuhabwa, T. Roskams, P.A.M. de Witte, and L. Baert Hypericin-based fluorescence diagnosis of bladder carcinoma BJU Int. 89 2002 760 763
15. A. Pytel, and N. Schmeller New aspect of photodynamic diagnosis of bladder tumors: fluorescence cytology Urology 59 2002 216 219
16. A.R. Kamuhabwa, I. Cosserat-Gerardin, J. Didelon, D. Notter, F. Guillemin, T. Roskams, M. D'Hallewin, L. Baert, and P.A.M. de Witte Biodistribution of hypericin in orthotopic transitional cell carcinoma bladder tumors: implication for whole bladder wall photodynamic therapy Int. J. Cancer 97 2002 253 260
17. H. Falk, J. Meyer, and M. Oberreiter A convenience semisynthetic route to hypericin Monatsh Chem. 124 1993 339 341
18. G. Hohlbrugger The vesical blood-urine barrier: a relevant and dynamic interface between renal function and nervous bladder control J. Urol. 154 1995 6 15
19. L. Liebes, Y. Mazur, D. Freeman, D. Lavie, G. Lavie, N. Kudler, S. Mendoza, B. Levin, H. Hochster, and D. Meruelo A method for the quantitation of hypericin, an antiviral agent, in biological fluids by high-performance liquid chromatography Anal. Biochem. 195 1991 77 85
20. J.D. Chi, and M. Franklin Determination of hypericin in plasma by high-performance liquid chromatography J. Chromatogr. B Biomed. Sci. Appl. 724 1999 195 198
21. R. Kerb, J. Brochmöller, B. Staffeldt, M. Ploch, and I. Roots Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin Antimicrob. Agents Chemother. 40 1996 2087 2093
22. C.M. Schempp, B. Winghofer, M. Langheinrich, E. Schopf, and J.C. Simon Hypericin levels in human serum and interstitial skin blister fluid after oral single-dose and steady-state administration of Hypericum perforatum extract (St John's wort). Skin Pharmacol. Appl. Skin Physiol. 12 1999 299 304
23. A.R. Kamuhabwa, P. Agostinis, M. D'Hallewin, A. Kasran, and P.A. de Witte Photodynamic activity of hypericin in human urinary bladder carcinoma cells Anticancer Res. 20 2000 2558 2579
24. A.L. Vandenbogaerde, E.M. Delaey, A.M. Vantieghem, B.E. Himpens, W.J. Merlevede, and P.A. de Witte Cytotoxicity and antiproliferative effect of hypericin and derivatives after photosensitization Photochem. Photobiol. 67 1998 119 125
25. J.M. Jacobson, L. Feinman, L. Liebes, N. Ostrow, V. Koslowski, A. Tobia, B.E. Cabana, D. Lee, J. Spritzler, and A.M. Prince Pharmacokinetics, safety, and antiviral effects of hypericin, a derivative of St. John's wort plant, in patients with chronic hepatitis C virus infection Antimicrob. Agents Chemother. 45 2001 517 524